Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

BUY
$4.26 - $6.84 $122,279 - $196,335
28,704 Added 121.19%
52,389 $244,000
Q2 2022

Aug 04, 2022

BUY
$8.35 - $21.89 $126,936 - $332,771
15,202 Added 179.21%
23,685 $248,000
Q1 2022

May 09, 2022

BUY
$16.97 - $31.93 $12,710 - $23,915
749 Added 9.68%
8,483 $175,000
Q4 2021

Feb 07, 2022

SELL
$25.61 - $41.78 $214,560 - $350,032
-8,378 Reduced 52.0%
7,734 $247,000
Q2 2021

Aug 06, 2021

SELL
$17.48 - $25.46 $111,487 - $162,383
-6,378 Reduced 28.36%
16,112 $365,000
Q1 2021

May 06, 2021

BUY
$18.08 - $28.8 $138,203 - $220,147
7,644 Added 51.49%
22,490 $515,000
Q4 2020

Feb 09, 2021

SELL
$11.7 - $23.41 $25,038 - $50,097
-2,140 Reduced 12.6%
14,846 $324,000
Q3 2020

Nov 10, 2020

SELL
$11.21 - $13.82 $2,163 - $2,667
-193 Reduced 1.12%
16,986 $199,000
Q2 2020

Aug 06, 2020

BUY
$9.8 - $12.77 $51,410 - $66,991
5,246 Added 43.96%
17,179 $196,000
Q1 2020

May 11, 2020

BUY
$8.78 - $18.6 $20,106 - $42,594
2,290 Added 23.75%
11,933 $133,000
Q4 2019

Feb 05, 2020

BUY
$13.12 - $17.06 $27,447 - $35,689
2,092 Added 27.7%
9,643 $159,000
Q3 2019

Nov 12, 2019

BUY
$12.75 - $19.01 $15,440 - $23,021
1,211 Added 19.1%
7,551 $104,000
Q2 2019

Aug 08, 2019

SELL
$17.0 - $21.88 $63,801 - $82,115
-3,753 Reduced 37.18%
6,340 $117,000
Q1 2019

Apr 26, 2019

BUY
$15.53 - $22.15 $18,418 - $26,269
1,186 Added 13.32%
10,093 $207,000
Q4 2018

Feb 08, 2019

SELL
$14.06 - $22.57 $21,160 - $33,967
-1,505 Reduced 14.45%
8,907 $138,000
Q3 2018

Nov 13, 2018

BUY
$13.35 - $19.1 $139,000 - $198,869
10,412 New
10,412 $179,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $288M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.